← SynDRA
DECLOPRAMIDE
SynDRA canonical compound SYN0025740 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | NFKB1 |
|---|
| Mechanism of action | cell cycle inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- cell cycle inhibitor
- DRD2 MODULATOR
- CHRM1 MODULATOR
Cross-references
Synonyms
- Declopramida
- IBD therapy, Active Biotech
- Inflammatory bowel disease therapy, Active Biotech
- OXi-104
- IMO-B project, Active Biotech
- 3-CPA
- 3-chloroprocainamide
- 4-Amino-3-chloro-N-[2-(diethylamino)ethyl]benzamide
- 4-amino-3-chloro-n-(2-(diethylamino)ethyl)benzamide
- declopramida
- 3-chloro-procainamide
- declopramidum
- RefChem:131321
- DTXCID00811219
- 3-Chloroprocainamide
- Declopramide [INN]
- UNII-916GJF577D
- YEYAKZXEBSVURO-UHFFFAOYSA-N
- SCHEMBL922516
- orb1700755
- SCHEMBL30719968
- BDBM611577
- AAA89160
- EBC-48123
- AKOS013640677
- US11717500, Compound Declopramide
- HY-111193
- CS-0034599
- NS00068630
- T27138
- EN300-1425545
- N-(2-diethylamino-ethyl)-4-amino-3-chlorobenzamide
- Benzamide, 4-amino-3-chloro-N-(2-(diethylamino)ethyl)-
- Z1222412146
- Declopramide hydrochloride
- DMJHWHGTAHHHMU-UHFFFAOYSA-N
- UNII-IP0ITJD3WD
- IP0ITJD3WD
- SCHEMBL6436822
Look up DECLOPRAMIDE in the interactive SynDRA portal →